Unexpected response to palliative radiotherapy for subcutaneous metastases of an advanced small cell pancreatic neuroendocrine carcinoma: a case report of two different radiation schedules

• Published in: BMC cancer 2020-04, Vol.20 (1), p.311-7, Article 311
• Main Authors: Ciliberti, Maria Paola, Carbonara, Roberta, Grillo, Antonietta, Leo, Anna Maria, Lolli, Ivan, Ostuni, Carmela, Troiani, Laura, Turi, Barbara, Vallarelli, Simona, Sardaro, Angela
• Format: Article
• Language: English
• Subjects: Cachexia; Cachexia - etiology; Cancer metastasis; Carcinoma; Carcinoma, Neuroendocrine - radiotherapy; Carcinoma, Small Cell - radiotherapy; Case Report; Case reports; Chemotherapy; Dose Fractionation, Radiation; Fatal Outcome; Female; Humans; Metastases; Metastasis; Middle Aged; Neuroendocrine tumors; Pain; Palliation; Palliative Care; Palliative radiotherapy; Pancreas; Pancreatic carcinoma; Pancreatic Neoplasms - radiotherapy; Pancreatic neuroendocrine carcinoma; Patients; Quality of life; Radiation (Physics); Radiation therapy; Radiotherapy; Scalp; Skin; Skin Neoplasms - radiotherapy; Skin Neoplasms - secondary; Subcutaneous metastases; Thorax
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-020-06845-x

Skin metastases from pancreatic neuroendocrine carcinoma (PNEC) are rare and their palliative treatment is challenging. We report our experience in the multimodal management of one of the few reported cases of metastatic PNEC with multiple visceral and subcutaneous secondary lesions, focusing on the effectiveness of palliative radiotherapy for skin metastases. A 61-years old woman affected by a metastatic PNEC - with subcutaneous growing and bleeding secondary lesions (at the scalp, right scapular region and at the back of the left thoracic wall, respectively) - obtained a successful control of visceral metastases with the use of chemotherapy and an unexpected local response of her skin metastases with palliative radiotherapy. In particular, two subsequent radiation treatments were performed using different fractionation schedules (30 Gy in 10 fractions and 20 Gy in 5 fractions, respectively). Both radiation treatments were well-tolerated and patient's quality of life was improved. Local response was maintained until patient's death - that occurred due to cachexia. The presented case highlights the effectiveness and the good tolerance of radiotherapy in the treatment of subcutaneous metastases; nevertheless, further knowledge of the optimal local palliative approach for PNEC metastatic sites is necessary. The experience gained in this work is the occasion to encourage a routine integrated multidisciplinary team management of metastatic PNECs because of their clinical complexity. The aim is to guarantee the optimization of the care with personalized and more effective systemic and local treatments - also including supportive cares and treatment-related side effects management.